Home / Belgium / Onward Medical
Onward Medical
Short position disclosed on November 5, 2026. FSMA register read on November 6, 2026.
Evolution of the disclosed total
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Securities (Europe) Limited | 0.53% | unchanged | November 5, 2026 |
On the other side: the funds that hold Onward Medical Titelia
Get the moves on Onward Medical by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| November 5, 2026 | Citadel Securities (Europe) Limited | 0.53% | still open |
Download 1 filing as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Belgium
- Solvay 2.30% of the capital sold short
- EVS 1.91% of the capital sold short
- Melexis 1.50% of the capital sold short
- Bekaert 0.84% of the capital sold short
- Azelis 0.70% of the capital sold short
- Umicore 0.70% of the capital sold short
- D'Ieteren Group 0.69% of the capital sold short
- Sequana Medical 0.65% of the capital sold short
- Lotus Bakeries 0.59% of the capital sold short
- Argenx 0.51% of the capital sold short
- Colruyt 0.50% of the capital sold short
- Montea 0.50% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Onward Medical, source FSMA, data as at November 5, 2026, https://www.quivad.com/action/onward-medical
Embed the chart
<iframe src="https://www.quivad.com/embed/action/onward-medical" width="600" height="280" title="Onward Medical" loading="lazy" style="border:0"></iframe>
Badge
<a href="https://www.quivad.com/action/onward-medical"><img src="https://www.quivad.com/action/onward-medical/badge.svg" alt="QuiVad, Onward Medical"></a>